Establishing secure connection…Loading editor…Preparing document…

Healthcare DSUR Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE DSUR REPORT

This Development Safety Update Report (DSUR) documents cumulative safety information for the investigational product and study(ies) identified below for the report period stated. All entries must be complete and truthful. Submitter certifies that identifiers have been removed to protect subject privacy and that information is accurate to the best of the submitter's knowledge.

Administrative Details

Report period: From to . DSUR number:

Exposure and Aggregate Safety Metrics

Total subjects exposed to investigational product during report period:

Cumulative subjects exposed to date: | New serious adverse events (SAEs) during period:

Deaths reported during period: | Withdrawals due to adverse events:

Individual Case Summaries (de-identified)

Case 1

DOB: | Gender: Male Female Other

Case 2 (if applicable)

DOB: | Gender: Male Female Other

Case 3 (if applicable)

DOB: | Gender: Male Female Other

Medical History and Concomitant Medications (Aggregate)

Safety Findings and Analysis

Neurological events Cardiac events Hepatic events Other

Actions Taken and Recommendations

Benefit–Risk Conclusion

Attachments and Appendices

Privacy, Certification, and Legal Statement

By submitting this DSUR, the undersigned certifies that subject-level data included in individual case summaries are de-identified in accordance with applicable privacy regulations. Personal identifiers have been removed and disclosure risk has been minimized. The undersigned further certifies that the information provided is complete, accurate to the best of their knowledge, and that material safety information known to the sponsor that could affect subject safety has been disclosed.

Acknowledgment of Privacy Statement: I certify that the data herein are de-identified and that appropriate privacy protections have been applied.

Certification and Signature

Printed Name:

Title:

Organization:

Signature:

Date:

Contact Phone:

Enter text✕

What the Healthcare DSUR Report Is and when it is used

The Healthcare DSUR Report is a standardized periodic safety document sponsors use to summarize cumulative safety information for an investigational medicinal product over a defined reporting interval. It compiles individual case safety reports, exposure estimates, aggregate analyses, and a structured risk–benefit assessment to support ongoing participant safety monitoring. DSURs follow internationally harmonized formats used across multi‑regional clinical programs and can be adapted to satisfy U.S. regulatory reporting practices where sponsors operate globally. The report also records actions taken and planned to mitigate identified risks.

Why a clear DSUR matters for safety oversight

A Healthcare DSUR Report consolidates safety data, clarifies trends, and documents sponsor decisions during the reporting period. It supports regulatory and ethical review by providing a consistent, auditable account of cumulative safety and recommended risk‑mitigation actions.

Why a clear DSUR matters for safety oversight

Who typically prepares and reviews DSURs

Typical users include clinical trial sponsors, pharmacovigilance officers, regulatory affairs teams, and IRBs who review cumulative safety information.

  • Sponsor safety and clinical operations teams responsible for compiling and interpreting aggregate safety data
  • Regulatory affairs professionals preparing submissions and responding to FDA or foreign health authority queries
  • Institutional Review Boards and independent ethics committees monitoring participant safety across sites

Use DSURs to ensure consistent safety assessment across regions and to maintain documentation required for audits and regulatory inspections.

Core sections every professional DSUR should include

A professional Healthcare DSUR Report includes standardized sections for administrative data, exposure, cumulative safety summaries, analysis, conclusions, and proposed risk‑mitigation actions.

Administrative Data

Identifies sponsor, study identifiers, reporting period, contact points, and document history. Accurate administrative data ensures traceability during audits and links to IND or CTA records.

Exposure Data

Summarizes patient exposure by country, dose, arm, and duration. Precise denominators enable incidence rate calculations and contextualize adverse event frequencies.

Individual Case Reports

Lists serious unexpected adverse reactions with narrative summaries and standardized coding. Line listings support case-level review of causality and consistency.

Aggregate Analysis

Presents aggregate safety statistics, trends, and subgroup findings. Highlight new patterns and observed‑versus‑expected comparisons that may indicate signals.

Risk–Benefit Assessment

Provides a structured assessment of overall benefit versus risk during the reporting period and states whether the benefit–risk profile has changed.

Actions & Recommendations

Documents actions taken or planned (protocol amendments, site notifications, labeling or temporary holds) and assigns responsible parties and timelines.

Essential DSUR data fields at a glance

Sponsor Name: Legal entity responsible for the study
Study ID: Protocol identifier and version
Reporting Period: Start and end dates MM/DD/YYYY
Number of Subjects: Total randomized and exposed counts
Serious Adverse Events: Count and classification by seriousness
Causality Assessments: Investigator and sponsor causality conclusions

Stepwise process to compile a Healthcare DSUR

Follow these steps to compile, review, and finalize a Healthcare DSUR Report for a single reporting period.

  • 01
    Gather source data: Collect case reports, exposure, and lab data
  • 02
    Run aggregate analyses: Compute incidence and trend summaries
  • 03
    Draft narrative sections: Write safety summary, assessment, and actions
  • 04
    Internal review and submission: Obtain PV and regulatory sign-off, file

How to set up an online DSUR workflow

Configure an online DSUR workflow to automate field mapping, reviewer routing, versioning, and eSignature capture for efficient submissions.

Field Configuration
Field mapping Auto-extract case data to DSUR sections
Reviewer routing Sequential PV then regulatory reviewer approval
Version control Automatic version history and audit trail
eSignature settings Require signer authentication, timestamp, and certificate

Typical flow from compilation to submission

Typical DSUR submission process from compilation through internal review and regulatory transmission, including recordkeeping and audit trail capture.

  • Compile: Aggregate case, exposure, and analysis tables
  • Review: PV and medical review for causality and signal
  • Approve: Regulatory sign-off with documented rationale
  • Submit: Send to authorities and archive signed report

Technical requirements for DSUR eSubmission and storage

Use platforms that support secure storage, audit trails, multi-factor authentication, and HIPAA-compliant workflows for DSUR compilation and eSubmission.

  • Formats: PDF, PDF/A, DOCX support
  • Integrations: EHR, safety DBs, CTMS
  • Authentication: MFA, SSO, audit timestamps

Ensure integration with clinical databases and safety systems, support for PDF/A exports, replayable audit trails, and retention policies aligned with HIPAA and FDA recordkeeping. Confirm vendor certifications and ability to produce tamper-evident signed PDFs for inspection purposes.

Timing considerations and typical preparation windows

Key DSUR timing obligations and typical submission windows for ongoing safety reporting and related regulatory filings.

Reporting period end:

Define exact start and end dates for interval

Draft completion:

Allow 4–6 weeks for analysis and drafting

Internal review:

Allocate 1–2 weeks for PV and medical review

Regulatory submission:

Meet sponsor or authority-specific filing windows

Archival retention:

Store final signed DSUR per retention policies

Common pitfalls in DSUR preparation

  • Incomplete exposure denominators that prevent accurate incidence calculations, causing misinterpretation of adverse event rates and delaying regulatory assessment.
  • Inconsistent case listing formats across sites that complicate aggregation, increase review time, and elevate risk of transcription errors.
  • Late receipt of investigator reports or lab data that forces last-minute revisions, potentially missing internal review deadlines.
  • Insufficient documentation of causality assessments and decision rationale, which undermines regulatory confidence and complicates inspections.

Regulatory risks and consequences of inaccurate reporting

Regulatory Action: FDA enforcement or warning letter
Clinical Hold: Enrollment suspension or study hold
Financial Penalties: Fines for reporting failures
Safety Reporting Rule: Noncompliance with 21 CFR §312.32
HIPAA Exposure: Breach fines under HIPAA rules
Reputation Risk: Loss of trust and trial delays

eSignature vendor feature and price comparison for DSUR workflows

Compare common eSignature vendors and starting prices to evaluate suitability for Healthcare DSUR workflows that require security, audit trails, and HIPAA considerations.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes Varies by plan
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes Varies Varies

Frequently asked questions about Healthcare DSUR Reports

Answers to common questions about preparing, signing, and submitting Healthcare DSUR Reports, including format, signatories, and privacy considerations.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users